SCHEMBL15922741

SCHEMBL15922741

C1CN(C23CC4CC(CC(C4)C2)C3)C1

nearest known ligand 0.48

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
TP53 P04637 1/20 0.39
HSD11B1 P28845 2/20 0.37
L3MBTL1 Q9Y468 1/20 0.37
SMN1; SMN2 Q16637 3/20 0.35
TSHR P16473 2/20 0.35
MAPK1 P28482 2/20 0.35
POLB P06746 2/20 0.35
TDP1 Q9NUW8 1/20 0.35
MEN1 O00255 1/20 0.35
KMT2A Q03164 1/20 0.35
HSD17B10 Q99714 1/20 0.35
LMNA P02545 2/20 0.35
SLC22A2 O15244 1/20 0.35
SLC22A1 O15245 1/20 0.35
GRIN2D O15399 1/20 0.35
GRIN3B O60391 1/20 0.35
NFKB1 P19838 1/20 0.35
STAT6 P42226 1/20 0.35
GRIN1 Q05586 1/20 0.35
GRIN2A Q12879 1/20 0.35

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL1143530 0.97 TP53 (0.41) TP53HSD11B1L3MBTL1SMN1; SMN2TSHR
SCHEMBL11355878 0.94 HSD11B1 (0.41) TP53HSD11B1L3MBTL1SMN1; SMN2TSHR
SCHEMBL10436532 0.92 HSD11B1 (0.43) TP53HSD11B1L3MBTL1SMN1; SMN2TSHR
SCHEMBL15922928 0.92 HSD11B1 (0.43) TP53HSD11B1L3MBTL1SMN1; SMN2TSHR
SCHEMBL15922897 0.88 TP53 (0.41) TP53HSD11B1L3MBTL1SMN1; SMN2TSHR
Ammonia Solution, Strong SCHEMBL27892508 0.87 HSD11B1 (0.41) TP53HSD11B1L3MBTL1SMN1; SMN2TSHR
SCHEMBL455945 0.78 TP53 (0.36) TP53SMN1; SMN2TSHRMAPK1POLB
SCHEMBL19073248 0.77 TP53 (0.36) TP53SMN1; SMN2TSHRMAPK1POLB
SCHEMBL1150375 0.77 KDM4E (0.48) TP53SMN1; SMN2TSHRMAPK1MEN1
SCHEMBL18177915 0.77 HTT (0.47) TP53HSD11B1SMN1; SMN2TSHRMAPK1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-9840465-B2 Antiviral compounds UNIV BRIGHAM YOUNG (US) 2017-12-12 US disclosed
US-20150368196-A1 ANTIVIRAL COMPOUNDS UNIV BRIGHAM YOUNG (US) 2015-12-24 US disclosed
EP-2950789-A2 ANTIVIRAL COMPOUNDS Brigham Young University (US) 2015-12-09 EP disclosed
WO-2014121170-A2 ANTIVIRAL COMPOUNDS BRIGHAM YOUNG UNIVERSITY (US) 2014-08-07 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20150368196-A1 ANTIVIRAL COMPOUNDS ACE, ADA, MAVS TP53 2064/4885HSD11B1 1386/4885L3MBTL1 3444/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.